Cargando…
SARS-CoV-2 variant Omicron: currently the most complete “escapee” from neutralization by antibodies and vaccines
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795721/ https://www.ncbi.nlm.nih.gov/pubmed/35091532 http://dx.doi.org/10.1038/s41392-022-00880-9 |
| _version_ | 1784641134561067008 |
|---|---|
| author | Li, Maochen Lou, Fuxing Fan, Huahao |
| author_facet | Li, Maochen Lou, Fuxing Fan, Huahao |
| author_sort | Li, Maochen |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8795721 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87957212022-01-28 SARS-CoV-2 variant Omicron: currently the most complete “escapee” from neutralization by antibodies and vaccines Li, Maochen Lou, Fuxing Fan, Huahao Signal Transduct Target Ther Research Highlight Nature Publishing Group UK 2022-01-28 /pmc/articles/PMC8795721/ /pubmed/35091532 http://dx.doi.org/10.1038/s41392-022-00880-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Research Highlight Li, Maochen Lou, Fuxing Fan, Huahao SARS-CoV-2 variant Omicron: currently the most complete “escapee” from neutralization by antibodies and vaccines |
| title | SARS-CoV-2 variant Omicron: currently the most complete “escapee” from neutralization by antibodies and vaccines |
| title_full | SARS-CoV-2 variant Omicron: currently the most complete “escapee” from neutralization by antibodies and vaccines |
| title_fullStr | SARS-CoV-2 variant Omicron: currently the most complete “escapee” from neutralization by antibodies and vaccines |
| title_full_unstemmed | SARS-CoV-2 variant Omicron: currently the most complete “escapee” from neutralization by antibodies and vaccines |
| title_short | SARS-CoV-2 variant Omicron: currently the most complete “escapee” from neutralization by antibodies and vaccines |
| title_sort | sars-cov-2 variant omicron: currently the most complete “escapee” from neutralization by antibodies and vaccines |
| topic | Research Highlight |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795721/ https://www.ncbi.nlm.nih.gov/pubmed/35091532 http://dx.doi.org/10.1038/s41392-022-00880-9 |
| work_keys_str_mv | AT limaochen sarscov2variantomicroncurrentlythemostcompleteescapeefromneutralizationbyantibodiesandvaccines AT loufuxing sarscov2variantomicroncurrentlythemostcompleteescapeefromneutralizationbyantibodiesandvaccines AT fanhuahao sarscov2variantomicroncurrentlythemostcompleteescapeefromneutralizationbyantibodiesandvaccines |